Cancer news

The latest news in cancer research, health and policy by Cancer Research UK.

We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy. 

Non Hodgkin Lymphoma

Cancer Research UK announces new chief medical officer for the Centre for Drug Development

Professor Peter Johnson will be the new chief medical officer for Cancer Research UK’s Centre for Drug Development.

Glioblastoma and children’s brain tumours: teams awarded £18 million Cancer Research UK Brain Tumour Awards

Three research teams have been awarded a combined total of £18 million to break new ground in the way we understand brain tumours and how they develop.

The scientists on a mission to revolutionise brain tumour research

Meet our three new international teams of scientists that have been awarded £18 million to revolutionise brain tumour research.

News digest – NHS waiting times, prostate cancer scans, drug decisions and gut bacteria

In the news this week: NHS waiting times for cancer treatment ‘continue to spiral downwards’.

Cancer Research UK to test targeted drug in pancreatic cancer

A dual kinase inhibitor is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine.

Kidney and lung cancer drugs approved on the NHS in Scotland

One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.

News digest – obesity projections, immunotherapy trials, Vitamin D and cancer ‘cure’ documentaries

In the news this week: The low-down from the world’s largest cancer conference and the dangerous documentaries spreading misinformation about cancer.

Targeted drug trial points to potential ‘new age’ for pancreatic cancer treatment

A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.

Immunotherapy comparable to chemo for some advanced stomach cancers

An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.

Precision drug combo boosts survival in younger women with advanced breast cancer

Combining a targeted drug with hormone therapy extended the lives of pre-menopausal women with advanced breast cancer in a clinical trial.

Pages